Literature DB >> 4333146

Escape from inhibition or resorption in cultures of fetal bone treated with calcitoninand parathyroid hromone.

J A Wener, S J Gorton, L G Raisz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4333146     DOI: 10.1210/endo-90-3-752

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  35 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  Effect of osteoclast activating factor from human leukocytes on bone metabolism.

Authors:  L G Raisz; R A Luben; G R Mundy; J W Dietrich; J E Horton; C L Trummel
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

3.  Bone resorption in organ culture: inhibition by the divalent cation ionophores A23187 and X-537A.

Authors:  J L Ivey; D R Wright; A H Tashjian
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

Review 4.  Assessment of renal and skeletal components of hypercalcemia.

Authors:  D J Hosking
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

5.  Comparison of the effects of amino-terminal synthetic parathyroid hormone-related peptide (PTHrP) of malignancy and parathyroid hormone on resorption of cultured fetal rat long bones.

Authors:  L G Raisz; H A Simmons; S J Vargas; B E Kemp; T J Martin
Journal:  Calcif Tissue Int       Date:  1990-04       Impact factor: 4.333

6.  Effects of forskolin on bone resorption in the absence and presence of parathyroid hormone and calcitonin.

Authors:  H H Conaway; R L Abraham; C L Wadkins
Journal:  Calcif Tissue Int       Date:  1987-05       Impact factor: 4.333

7.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

Review 8.  Hypercalcaemia of malignancy.

Authors:  P J Kelly; J A Eisman
Journal:  Cancer Metastasis Rev       Date:  1989-06       Impact factor: 9.264

9.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.